English Name:(2s,4s)-2-(5-(1,11-dihydro-2-((2s,5s)-1-((2s)-2-((methoxycarbonyl)amino)-3-methyl-1-oxobutyl)-5-methyl-2-pyrrolidinyl)(2)benzopyrano(4',3':6,7)naphth(1,2-d)imidazol-9-yl)-1h-imidazol-2-yl)-4-(methoxymethyl)-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester
Founded in 2007, Shanghai Twisun Bio-pharm Co., Ltd. is a professional national Hi-tech manufacturer, which unifies R&D, produce, sale and service for high level advanced intermediates, APIs, special chemicals and natural medicine. Registered capital is $2.6 million, fixed assets is more than $16 million. Twisun's headquarters is located in Shanghai Jinshan No.2 industry area, production bases are in Anhui and Jiangxi province, total area is 100000 ㎡, more than 300 staffs. The annual sales break...
View more >>
Basic Information
Business Type: Manufacturer,Trading Company,Other
Product/Service (We Buy): 101 - 500 People
Ownership Type: Individual (Sole proprietorship)
Registered Capital: US$2.5 Million - US$5 Million
Year Established: 2007
Number of Employees: 101 - 500 People
Trade & Market
Main Markets: Mid East,Africa,Eastern Asia
QA/QC: In House
Number of Production Lines: 6
Number of R&D Staff: 106
Number of QC Staff: 5 - 10 People
Total Annual Sales Volume: US$50 Million - US$100 Million